Home > Publications database > Transglycosylation toward naringenin-7-O-glucoside using an N180H mutant of Coprinopsis cinerea endo-β-N-acetylglucosaminidase > print

001     885457
005     20210208142400.0
024 7 _ |a 10.1016/j.bbrc.2020.06.128
|2 doi
024 7 _ |a 0006-291X
|2 ISSN
024 7 _ |a 1090-2104
|2 ISSN
024 7 _ |a 2128/26992
|2 Handle
024 7 _ |a 32828279
|2 pmid
024 7 _ |a WOS:000565184300025
|2 WOS
037 _ _ |a FZJ-2020-03840
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Ohashi, Takao
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Transglycosylation toward naringenin-7-O-glucoside using an N180H mutant of Coprinopsis cinerea endo-β-N-acetylglucosaminidase
260 _ _ |a Orlando, Fla.
|c 2020
|b Academic Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1611559393_2888
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Flavonoids are generally glycosylated, and the glycan moieties of flavonoid glycosides are known to greatly affect their physicochemical and biological properties. Thus, the development of a variety of tools for glycan remodeling of flavonoid glycosides is highly desired. An endo-β-N-acetylglucosaminidase mutant Endo-CC N180H, which is developed as an excellent chemoenzymatic tool for creating sialylglycoproteins, was employed for the glycosylation of flavonoids. Endo-CC N180H transferred the sialyl biantennary glycans from the sialylglyco peptide to pNP-GlcNAc and narigenin-7-O-glucoside. The kinetic parameters of Endo-CC N180H towards SGP and pNP-GlcNAc were determined. Flavonoid glucosides harboring a 1,3-diol structure in the glucose moieties acted as substrates of Endo-CC N180H. We proposed that the sialyl biantennary glycan transfer to the flavonoid by Endo-CC N180H could pave the way for the improvement of the inherent biological functions of the flavonoids and creation of novel flavonoid glycoside derivatives for future human health benefits including foods and drugs.
536 _ _ |a 581 - Biotechnology (POF3-581)
|0 G:(DE-HGF)POF3-581
|c POF3-581
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Fujisawa, Yu
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Hayes, Marc
|0 P:(DE-Juel1)159276
|b 2
|u fzj
700 1 _ |a Misaki, Ryo
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Pietruszka, Jörg
|0 P:(DE-Juel1)128906
|b 4
|u fzj
700 1 _ |a Fujiyama, Kazuhito
|0 P:(DE-HGF)0
|b 5
|e Corresponding author
773 _ _ |a 10.1016/j.bbrc.2020.06.128
|g Vol. 530, no. 1, p. 155 - 159
|0 PERI:(DE-600)1461396-7
|n 1
|p 155 - 159
|t Biochemical and biophysical research communications
|v 530
|y 2020
|x 0006-291X
856 4 _ |y Restricted
|u https://juser.fz-juelich.de/record/885457/files/11-1-s2.0-S0006291X20313462-main-1.pdf
856 4 _ |y Published on 2020-07-13. Available in OpenAccess from 2021-07-13.
|z StatID:(DE-HGF)0510
|u https://juser.fz-juelich.de/record/885457/files/11-Ohashi-FlavonoidEndoEnz2020.pdf
909 C O |o oai:juser.fz-juelich.de:885457
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Osaka Universität
|0 I:(DE-HGF)0
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Osaka Universität
|0 I:(DE-HGF)0
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)159276
910 1 _ |a Heinrich-Heine-Universität Düsseldorf
|0 I:(DE-HGF)0
|b 2
|6 P:(DE-Juel1)159276
910 1 _ |a Osaka Universität
|0 I:(DE-HGF)0
|b 3
|6 P:(DE-HGF)0
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)128906
910 1 _ |a Heinrich-Heine-Universität Düsseldorf
|0 I:(DE-HGF)0
|b 4
|6 P:(DE-Juel1)128906
910 1 _ |a Osaka Universität
|0 I:(DE-HGF)0
|b 5
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Key Technologies
|l Key Technologies for the Bioeconomy
|1 G:(DE-HGF)POF3-580
|0 G:(DE-HGF)POF3-581
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-500
|4 G:(DE-HGF)POF
|v Biotechnology
|x 0
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-01-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-01-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2020-01-09
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BIOCHEM BIOPH RES CO : 2018
|d 2020-01-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-09
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2020-01-09
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-09
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2020-01-09
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2020-01-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-01-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-01-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-09
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2020-01-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-09
920 _ _ |l no
920 1 _ |0 I:(DE-Juel1)IBOC-20090406
|k IBOC
|l Institut für Bioorganische Chemie (HHUD)
|x 0
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBOC-20090406
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21